1.

Association of common polymorphisms in known susceptibility genes with rheumatoid arthritis in a Slovak population using osteoarthritis patients as controls.

Stark K, Rovenský J, Blazicková S, Grosse-Wilde H, Ferencik S, Hengstenberg C, Straub RH.

Arthritis Res Ther. 2009;11(3):R70. Epub 2009 May 15

 

2.

Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor.

Fischer JC, Ottinger H, Ferencik S, Sribar M, Punzel M, Beelen DW, Schwan MA, Grosse-Wilde H, Wernet P, Uhrberg M.

J Immunol. 2007 Mar 15;178(6):3918-23.

 

3.

Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias.

Beelen DW, Ottinger HD, Ferencik S, Elmaagacli AH, Peceny R, Trenschel R, Grosse-Wilde H.

Blood. 2005 Mar 15;105(6):2594-600. Epub 2004 Nov 9.

 

4.

Impact of HLA-A,B,C allele mismatches on outcome after unrelated blood stem cell transplantation in whites.

Ottinger HD, Ferencik S, Beelen DW, Lindemann M, Peceny R, Elmaagacli AH, Grosse-Wilde H.

Transplantation. 2004 Oct 15;78(7):1077-80.

 

5.

Molecular genetic and biochemical analysis of woodchuck (Marmota monax) MHC class I polymorphism.

Zhou JH, Ferencik S, Rebmann V, Yang DL, Lu M, Roggendorf M, Grosse-Wilde H.

Tissue Antigens. 2003 Mar;61(3):240-8.

 

6.

Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors.

Ottinger HD, Ferencik S, Beelen DW, Lindemann M, Peceny R, Elmaagacli AH, Husing J, Grosse-Wilde H.

Blood. 2003 Aug 1;102(3):1131-7. Epub 2003 Apr 10.

 

7.

Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells.

Ottinger HD, Müller CR, Goldmann SF, Albert E, Arnold R, Beelen DW, Blasczyk R, Bunjes D, Casper J, Ebell W, Ehninger G, Eiermann T, Einsele H, Fauser A, Ferencik S, Finke J, Hertenstein B, Heyll A, Klingebiel T, Knipper A, Kremens B, Kolb HJ, Kolbe K, Lenartz E, Lindemann M, Müller CA, Mytilineos J, Niederwieser D, Runde V, Sayer H, Schaefer UW, Schmitz N, Schröder S, Schulze-Rath R, Schwerdtfeger R, Siegert W, Thiele B, Zander AR, Grosse-Wilde H.

Ann Hematol. 2001 Dec;80(12):706-14. Epub 2001 Oct 25. Review.

 

8.

HLA-DR expression and soluble HLA-DR levels in septic patients after trauma.

Ditschkowski M, Kreuzfelder E, Rebmann V, Ferencik S, Majetschak M, Schmid EN, Obertacke U, Hirche H, Schade UF, Grosse-Wilde H.

Ann Surg. 1999 Feb;229(2):246-54.

 

9.

Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.

Büdinger L, Borradori L, Yee C, Eming R, Ferencik S, Grosse-Wilde H, Merk HF, Yancey K, Hertl M.

J Clin Invest. 1998 Dec 15;102(12):2082-9.

 

10.

Recurrence of Hodgkin's disease after 10 or more years: late relapse or de-novo malignancy due to HLA-DPB1*0301-linked susceptibility?

Siebert R, Fosså A, Kaiser W, Welt A, Ferencik S, Seeber S, Nowrousian MR.

Leuk Lymphoma. 1997 Jun;26(1-2):121-5.

 

11.

A simple photometric detection method for HLA-DRB1 specific PCR-SSP products.

Ferencik S, Grosse-Wilde H.

Eur J Immunogenet. 1993 Apr;20(2):123-5.